OABI
NASDAQOmniAb Inc.
News25/Ratings5
News · 26 weeks42-43%
2026-01-182026-07-12
Mix2090d
- Insider9(45%)
- SEC Filings6(30%)
- Earnings3(15%)
- Other1(5%)
- Leadership1(5%)
Latest news
25 items- PROmniAb to Report Second Quarter 2026 Financial Results on August 6OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on Thursday, August 6, 2026, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast What: OmniAb conference call to discuss second quarter 2026 financial results and business updates Date: Thursday, August 6, 2026 Time: 4:30 p.m. E
- INSIDERSEC Form 3 filed by new insider Nwachuku Amechi Ekeke3 - OmniAb, Inc. (0001846253) (Issuer)
- SECOmniAb Inc. filed SEC Form 8-K: Leadership Update8-K - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb Names Amechi Nwachuku Chief Operating OfficerOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it has appointed Amechi Nwachuku to the newly-created position of Executive Vice President and Chief Operating Officer, effective today. Mr. Nwachuku will be primarily responsible for managing the strategy, operations and commercial maximization of xPloration®, OmniAb’s proprietary, innovative high-throughput single B-cell screening platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713808637/en/ Mr. Nwachuku has more than 25 years of experience, including leading m
- INSIDERDirector Bertozzi Carolyn R converted options into 20,000 shares, increasing direct ownership by 21% to 113,308 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERDirector Cochran Jennifer R. converted options into 20,000 shares, increasing direct ownership by 12% to 185,274 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERDirector Crouse Steven C. converted options into 20,000 shares, increasing direct ownership by 150% to 33,333 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERDirector Gotwals Philip J converted options into 20,000 shares, increasing direct ownership by 150% to 33,333 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERDirector Higgins John L converted options into 20,000 shares, increasing direct ownership by 0.68% to 2,962,320 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERDirector Love Steven converted options into 20,000 shares, increasing direct ownership by 28% to 91,666 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- SECOmniAb Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - OmniAb, Inc. (0001846253) (Filer)
- SECSEC Form 10-Q filed by OmniAb Inc.10-Q - OmniAb, Inc. (0001846253) (Filer)
- SECOmniAb Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb Reports First Quarter 2026 Financial Results and Business HighlightsConference Call Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and increased 2026 financial guidance. "OmniAb experienced strong momentum during the first quarter as multiple partnered programs advanced into later-stage clinical development, reinforcing the diversity and value of our portfolio. With a very strong start to the year, we are raising our 2026 revenue guidance," stated Matt Foehr, Chief Executive Officer of OmniAb. "Continued progression of partner programs highlights the value of our technology platform and positions our business wel
- SECSEC Form DEF 14A filed by OmniAb Inc.DEF 14A - OmniAb, Inc. (0001846253) (Filer)
- SECSEC Form DEFA14A filed by OmniAb Inc.DEFA14A - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb to Participate in Three Upcoming Investor ConferencesOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in three investor conferences over the coming weeks. H.C. Wainwright 2nd Annual Royalty Company Virtual Conference, May 6. Management will participate in a fireside chat on Wednesday, May 6th. Benchmark 6th Annual Healthcare House Call Virtual Investor Conference, May 28. Management will hold virtual one-on-one and small group meetings with investors on Thursday, May 28th. Jefferies Global Healthcare Conference, June 2-4 at the Marriott Marquis in New York City. Management will present a corporate overview on Wednesday, June 3rd at 4:55 p.m. Eastern time and will hold one-on-one meetings with investors
- INSIDERSEC Form 4 filed by Gotwals Philip J4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERSEC Form 4 filed by Crouse Steven C.4 - OmniAb, Inc. (0001846253) (Issuer)
- PROmniAb to Report First Quarter 2026 Financial Results on May 7OmniAb, Inc. (NASDAQ:OABI) will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on Thursday, May 7, 2026, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss first quarter 2026 financial results and business updates Date: Thursday, May 7, 2026 Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time) Phone: U.S. (833) 461-5787 Internati
- SECSEC Form 144 filed by OmniAb Inc.144 - OmniAb, Inc. (0001846253) (Subject)
- INSIDERSEC Form 4 filed by Foehr Matthew W4 - OmniAb, Inc. (0001846253) (Issuer)
- SECSEC Form 144 filed by OmniAb Inc.144 - OmniAb, Inc. (0001846253) (Subject)
- INSIDERSEC Form 4 filed by Gustafson Kurt A4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERSEC Form 4 filed by Berkman Charles S4 - OmniAb, Inc. (0001846253) (Issuer)
OABI FAQ
6 questionsWhere does OABI stock trade?
OmniAb Inc. (OABI) is listed on NASDAQ.What sector and industry is OABI in?
OmniAb Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did OmniAb Inc. go public?
OmniAb Inc. (OABI) completed its IPO in 2021.What are analysts saying about OABI?
OmniAb Inc. has had 5 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Outperform with a $600.00 price target on 2023-11-29. Recent price targets range from $600.00 to $1100.00.What companies are similar to OABI?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), PPD (PPD, Inc.), MEDP (Medpace Holdings Inc.), ICLR (ICON plc). Compare OABI side-by-side with any of them on Quantisnow.How can I track OABI on Quantisnow?
Quantisnow aggregates OmniAb Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OABI to receive live email and push alerts on every new disclosure.